Skip to main content

View full-text article in PMC

. 2018 Dec 21;13(12):e0209338. doi: 10.1371/journal.pone.0209338

Table 2. The association between EMX2OS expression and the clinicopathological parameters in classical PTC patients.

		EMX2OS expression		p value
		High (N = 211)	Low (N = 134)	p value
Age (Mean ± SD)		47.89±1.13	43.83±1.34	0.02
Gender	Female	151(72%)	100(75%)	0.62
Gender	Male	60(28%)	34(25%)	0.62
Pathological Stage	III/IV	76(36%)	34(25%)	0.044
Pathological Stage	I/II	135(64%)	100(75%)	0.044
Residual tumors	R0	151(72%)	110(82%)	0.011
	R1/R2	34(16%)	9(7%)	0.011
	RX/no data	26(12%)	15(11%)
Radiation therapy	No	76(36%)	53(40%)	0.65
	Yes	126(60%)	79(59%)	0.65
	No data	9(4%)	2(1%)
Recurrence status	No	202(96%)	118(88%)	0.01
Recurrence status	Yes	9(4%)	16(12%)	0.01